Catastrophic anti-phospholipid syndrome with Libman-Sacks endocarditis following eltrombopag therapy for immune thrombocytopenic purpura: A case report

1. Abrahamson, PE, Hall, SA, Feudjo-tepie, M, et al. The incidence of idiopathic thrombocytopenic purpura among adults: a population-based study and literature review. Eur J Haematol 2009; 83(2): 83–89.
Google Scholar | Crossref | Medline2. Garnock-Jones, KP . Eltrombopag: a review of its use in treatment-refractory chronic primary immune thrombocytopenia. Drugs 2011; 71(10): 1333–1353.
Google Scholar | Crossref | Medline3. Bussel, JB, Cheng, G, Saleh, MN, et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med 2007; 357(22): 2237–2247.
Google Scholar | Crossref | Medline | ISI4. Burness, CB . Eltrombopag: a review of its use in the treatment of thrombocytopenia in patients with chronic hepatitis C. Drugs 2014; 74: 1961–1971.
Google Scholar | Crossref | Medline5. GlaxoSmithKline . PROMACTA (Eltrombopag) tablets: US prescribing information, http://www.gsksource.com/gskprm/htdocs/documents/PROMACTA-PI-MG-COMBINED.PDF (2014, accessed 26 August 2014).
Google Scholar6. Berg, T, Riordan, S, Karamanolis, D, et al..ENABLE-ALL: safety and efficacy of Eltrombopag in thrombocytopenic hepatitis C virus-infected patients with cirrhosis who withdraw from the ENABLE-1&2 studies (abstract no.140). In: 23rd annual conference of APASL, Brisbane, Australia, , 2014.
Google Scholar7. Afdhal, NH, Dusheiko, GM, Giannini, EG, et al. Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy. Gastroenterology 2014; 146(2): 442–452.
Google Scholar | Crossref | Medline8. Guitton, Z, Terriou, L, Lega, JC, et al. Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists. Rheumatology (Oxford) 2018; 57: 1432–1438. DOI: 10.1093/rheumatology/key119
Google Scholar | Crossref | Medline9. Yuridititsky, E, Torres, J, Izmirly, PM, et al. Resolution of large aortic valve vegetations in antiphospholipid syndrome treated with therapeutic anticoagulation: a report of two cases and literature review. Lupus 2018; 27(14): 2269–2273. DOI: 10.1177/0961203318804876
Google Scholar | SAGE Journals10. Atsumi, T, Furukawa, S, Amengual, et al. Antiphospholipid antibody associated thrombocytopenia and the paradoxical risk of thrombosis. Lupus 2005; 14(7): 499–504.
Google Scholar | SAGE Journals | ISI

留言 (0)

沒有登入
gif